CJC-1295 with DAC (5 mg)

CJC-1295 with DAC is a synthetic peptide combination designed for research applications in animal models. This product includes CJC-1295, a modified form of growth hormone-releasing hormone (GHRH), paired with desamino-cysteine-8 argin vasopressin (DAC), an analog of oxytocin. The combination is widely utilized in preclinical studies to investigate neuroendocrine regulation, muscle hypertrophy, and metabolic effects in controlled experimental settings.

Research Context

CJC-1295 with DAC was first developed in the 1990s as a potent peptide agonist for growth hormone secretagogues. The compound stimulates pituitary growth hormone (GH) release, which in turn enhances insulin-like growth factor 1 (IGF-1) production in target tissues. DAC, when administered together, modulates pituitary function by enhancing oxytocin activity, contributing to enhanced growth hormone responsiveness. This combination is particularly valuable in studies examining growth processes, muscle growth, and regenerative biology.

Research Overview

In preclinical research, CJC-1295 with DAC has been evaluated for its effects on:

• Growth hormone and IGF-1 axis modulation in animal models
• Muscle hypertrophy and skeletal development
• Neuroendocrine regulation and aging studies
• Metabolic and regenerative tissue repair

The peptide combination is administered via subcutaneous injection, typically in controlled dosages and protocols that are specific to the research design. It is important to note that these studies are conducted under strict regulatory oversight in accredited research facilities.

Key Research Focus Areas

• Growth and Development: CJC-1295 with DAC enhances growth hormone secretion, leading to increased IGF-1 levels. This can be used to investigate growth mechanisms in both juvenile and adult animals.
• Muscle and Skeletal Biology: The peptide has been studied for its role in muscle hypertrophy, bone formation, and overall skeletal integrity in animal models. It may influence collagen synthesis and tendon strength.
• Neuroendocrine Function: The oxytocin component (DAC) contributes to neuroendocrine regulation, affecting behaviors such as maternal care, social bonding, and stress responses. This combination is valuable in neurobiological research.
• Metabolic and Regenerative Studies: Investigations into how CJC-1295 with DAC influences metabolic pathways, including fat metabolism and tissue regeneration, are common in controlled laboratory settings.

Important Disclaimers

This product is intended solely for research purposes in accredited academic or institutional settings. It is not approved for therapeutic, diagnostic, cosmetic, or human or animal consumption. Research involving CJC-1295 with DAC must comply with all applicable regulatory guidelines, including those from the National Institutes of Health (NIH) or equivalent authorities in your region. Always follow protocols for proper handling, storage, and disposal of research chemicals.

For research use only. Not for human or animal consumption.